Seattle Genetics | DEBITO



Debt Cambiamento Data
AbbVie USD 67.14B 3.94B 2024-12
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
Astellas Pharma JPY 831.43B 83.94B 2025-03
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Celldex Therapeutics USD 0 0 2025-03
Daiichi Sankyo JPY 101.33B 97M 2025-03
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 0 0 2025-04
Genmab DKK 143M 886M 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 37.12M 840K 2025-03
Insmed USD 1.13B 981K 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 21.05B 3.14B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 4.52T 324.88B 2025-03
Teva Pharmaceutical Industries USD 16.65B 1.43B 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 154.38M 9.23M 2025-03



Seattle Genetics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.